GA SB220

Renames "low THC oil" to "medical cannabis" throughout Georgia Code and expands the definition to include any plant within the genus Cannabis and its derivatives containing tetrahydrocannabinol, with individual product packages limited to 1,200 milligrams of THC and patient possession capped at 12,000 milligrams cumulative.

Expands qualifying medical conditions to include any cancer (except non-metastatic skin cancer), lupus, severe arthritis, severe insomnia, and inflammatory bowel disease, while removing severity requirements for conditions like ALS, multiple sclerosis, Parkinson's, sickle cell disease, and Alzheimer's.

Allows vaporization of medical cannabis for adults over 21 (previously prohibited), while maintaining bans on smoking/combustion and public consumption; prohibits vaporization for individuals 21 and younger.

Authorizes licensees to provide information about legal and safe uses of medical cannabis to registered patients, and requires the Georgia Access to Medical Cannabis Commission to conduct public awareness and education activities about the program.

Extends registration card validity to five years (with annual physician certification for curable conditions), allows patients to receive electronic cards for immediate purchasing, expands caregiver definition to include designated adults and health care institutions, and prohibits excessive fees or regulations that would unduly burden patient access.